A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
- What to know about the upcoming flu season, vaccine
- Beyond the Opioid Epidemic: Scientist Seeks to Develop non-Addictive Treatment for Pain.
- Avoiding a “Tripledemic” This Winter.
- Overdose deaths from fentanyl combined with stimulants increased 50-fold since 2010.
- Flu season is approaching. Here’s what to expect in N.J.